Electrochemical ELISA Protein Biosensing in Undiluted Serum Using a Polypyrrole-Based Platform by Arya, Sunil & Estrela, Pedro
        
Citation for published version:
Arya, S & Estrela, P 2020, 'Electrochemical ELISA Protein Biosensing in Undiluted Serum Using a Polypyrrole-
Based Platform', Sensors, vol. 20, no. 10, 2857. https://doi.org/10.3390/s20102857
DOI:
10.3390/s20102857
Publication date:
2020
Document Version
Publisher's PDF, also known as Version of record
Link to publication
Publisher Rights
CC BY
University of Bath
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 05. Jun. 2020
sensors
Letter
Electrochemical ELISA Protein Biosensing in
Undiluted Serum Using a Polypyrrole-Based Platform
Sunil K. Arya 1,† and Pedro Estrela 1,2,*
1 Department of Electronic & Electrical Engineering, University of Bath, Claverton Down, Bath BA2 7AY, UK;
sunilarya333@gmail.com
2 Centre for Biosensors, Bioelectronics and Biodevices (C3Bio), University of Bath, Claverton Down,
Bath BA2 7AY, UK
* Correspondence: p.estrela@bath.ac.uk
† Current address: Sun Chemical Ltd., Norton Hill, Midsomer Norton, Bath BA3 4RT, UK.
Received: 15 April 2020; Accepted: 15 May 2020; Published: 18 May 2020


Abstract: An electrochemical enzyme-linked immunosorbent assay (ELISA) biosensor platform
using electrochemically prepared ~11 nm thick carboxylic functionalized popypyrrole film has been
developed for bio-analyte measurement in undiluted serum. Carboxyl polypyrrole (PPy-COOH) film
using 3-carboxy-pyrrol monomer onto comb-shaped gold electrode microarray (Au) was prepared via
cyclic voltammetry (CV). The prepared Au/PPy-COOH was then utilized for electrochemical ELISA
platform development by immobilizing analyte-specific antibodies. Tumor necrosis factor-alpha
(TNF-α) was selected as a model analyte and detected in undiluted serum. For enhanced performance,
the use of a polymeric alkaline phosphatase tag was investigated for the electrochemical ELISA.
The developed platform was characterized at each step of fabrication using CV, electrochemical
impedance spectroscopy and atomic force microscopy. The bioelectrodes exhibited linearity for
TNF-α in the 100 pg/mL–100 ng/mL range when measured in spiked serum, with limit of detection
of 78 pg/mL. The sensor showed insignificant signal disturbance from serum proteins and other
biologically important proteins. The developed platform was found to be fast and specific and can be
applicable for testing and measuring various biologically important protein markers in real samples.
Keywords: carboxyl polypyrrole; electrochemical ELISA; TNF-α; polymeric alkaline phosphatase;
biomarker; differential pulse voltammetry; biosensor
1. Introduction
The development of reliable, fast and cost-effective methods for biomarker analysis has gained
much needed attention for improved healthcare. The fast and accurate estimation of health biomarkers
using such methods at the early stages of diseases can provide good prognosis and better chances
for effective therapies [1–3]. Research in the biomedical diagnosis field has developed various
methods and devices based on e.g., optical, calorimetric and electrochemical techniques for such
estimation of biomarkers [4–9]. Among various techniques and methods, to date the use of the optical
enzyme-linked immunosorbent assay (ELISA) is considered as gold standard and used in real sample
testing [10]. In most cases, optical ELISA provides accurate and reliable data for biomarker detection;
however, it requires complex equipment, long timings and skilled workers for testing and maintenance.
Therefore, there is a demand for other simpler technologies to achieve high quality results in a shorter
time and with easier testing procedures. Recently, electrochemical immunosensors, exhibiting high
sensitivity, accuracy, simplicity and low cost, have received much attention [3,10,11]. Electrochemical
ELISA, which combines a sandwich ELISA approach with electrochemical detection, is a promising
technique that can provide high specificity due to the use of a sandwich assay and high sensitivity
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due to use of improved detection tags and electrochemical measurement [12]. However, to develop
better electrochemical ELISA tests that can replace optical ELISAs in healthcare systems, significant
research is still required and necessitate further collaborative efforts of researchers in various fields.
In one such area of improvement, research is required in finding suitable matrices for immobilization
of biomolecules, where the capturing molecule remains stable and active after immobilization, which is
crucial for sensor development and one of the deciding factors in stability of developed sensor [13,14].
As a matrix for biomolecule immobilization, conjugated conductive polymers (CP), owing to their
redox properties, electrical conductivity and compatibility with bioreceptor association, have attracted
significant attention in the past decade in biosensor development [15,16]. Among various CPs,
polypyrrole (PPy), known for its stability, conductivity and biocompatibility, has been the most
intensively investigated and widely employed in biosensor applications. However, PPy suffers
from the absence of functional groups and needs prior chemical modification to generate functional
chemical groups such as carboxylic acids or amines for the stable immobilization of biomolecules [16].
Such chemical modification is time consuming and can affect the PPy’s chemical structure and hinder
the conductivity of its backbone. In order to avoid a chemical modification step, in the present study we
have developed an electrochemical ELISA sensor platform employing 3-carboxy pyrrole (Py-COOH) for
polymerization and covalent binding of antibody using the carboxyl groups of polymer. PPy-COOH has
been used previously for electrochemically preparing nanothin films for electrochemical-transmission
surface plasmon resonance spectroscopy studies and for making biosensors for the detection of
human immunoglobulin G (IgG) [17,18]. Also, its copolymer with pyrrole has been utilized for
developing label-free impedimetric biosensors for Salmonella Typhimurium [16]. To the best of our
knowledge, this is the first report on using nanothin films of PPy-COOH for developing electrochemical
ELISA-based immunosensors.
Tumor necrosis factor-α protein (TNF-α) is a 157 amino acid long polypeptide forming a 47–55 kDa
trimer cytokine [19,20]. It has been reported to play a crucial role in various immune and inflammatory
progressions [21,22]. TNF-α exists in picogram per milliliter levels in the blood of healthy humans [23,24].
Studies by Milani et al. showed the TNF-α level in normal subjects to be 0.89 ± 0.40 pg/mL; range,
0.5 to 9.7 pg/mL [24]. However, it has been reported to increase by ten- to hundred-fold in the
case of pathological conditions like rheumatoid arthritis (RA), thus making it a useful inflammatory
biomarker [21,22,25,26]. Furthermore, TNF-α has been involved in many diseases like Crohn’s disease,
neurodegenerative diseases (Alzheimer’s, Parkinsons), rejection to clinical transplantation, sepsis,
and cancer, amongst others [27–32]. Apart from these diseases, it has also been shown to play negative
role in wound healing [33]. At present, TNF-α is determined using techniques such as optical ELISA,
radioimmunoassay and time resolve fluorescence assay [34–36]. Such techniques provide precise
estimation; however, they require complex, expensive equipment that can only be run in central
laboratories by skilled professionals.
In the present study, the advantages of carboxyl functionalized pyrrole (Py-COOH), electrochemical
ELISA and polymeric alkaline phosphatase (PALP) have been combined to achieve enhanced high
sensitivity with reliable estimation of TNF-α in spiked serum. PPy-COOH modified comb-shaped gold
microelectrodes have been used to covalently immobilize monoclonal TNF-α antibody. Non-specific
binding and false signals from detection in serum were avoided by the use of a blocker containing
proprietary proteins in phosphate buffer with Tween20. Furthermore, the use of PALP gives
higher loading of enzyme during binding, resulting in enhanced production of 4-aminophenol
from 4-aminophenyl phosphate (4-APP) biocatalyzation, thus giving an improved redox signal.
2. Materials and Procedures for Development and Testing
2.1. Chemicals
Primary monoclonal antibody (product code: 502802) and secondary monoclonal antibody
(product code: 502904) with attached biotin and TNF-α (product code: 570104) were purchased from
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BioLegend (San Diego, CA, USA). Alkaline phosphatase (ALP) and polymeric alkaline phosphatase
(PALP) with conjugated streptavidin (enhanced Strept-AP) (product code: 5150N) was purchased
from Kem-En-Tec Diagnostics (Taastrup, Denmark). Human serum (product code: H4522-100 mL)
from human male AB plasma was purchased from Sigma (Gillingham, UK). Starting blockers TBST20
(SB-TBST) and PBST20 (SB) were purchased from Fisher Scientific (Loughborough, UK). 4-APP
was purchased from Santa Cruz Biotechnology (Dallas, TX, USA). Pyrrole-3-carboxylic acid and
lithium perchlorate were purchased from Sigma and Femto TBST was obtained from G-Biosciences
(St. Louis, MO, USA). The rest of the chemicals and reagents used were of analytical grade and used
without modification.
2.2. Apparatus
Electrochemical impedance spectroscopy (EIS) and cyclic voltammetry (CV) measurements were
performed using a µAutolab III/FRA2 potentiostat/galvanostat (Metrohm, Netherlands) running
on NOVA software. For EIS measurements, separate gold electrodes were used as counter and
pseudo reference electrodes, respectively, and the developed electrode at each step was used as
the working electrode. Measurements were performed in the 100 kHz–100 mHz frequency range,
at applied AC amplitude of 25 mV and open circuit potential, i.e., equilibrium potential existed between
electrodes incubated in test solution, without external biasing. Electrode development was also
characterized via cyclic voltammetry (CV). CV and EIS studies were performed in 0.1 M KCl (50 µL)
containing 5 mM [Fe(CN)6]3−/4− as a redox probe. PPy-COOH deposition was also characterized using
atomic force microscopy (AFM) imaging in ambient contact mode and scanning electron microscopy.
AFM investigations were carried out via MultiMode NanoScope (Bruker, Germany). The AFM
system utilized version 6 software with IIIa controller. For imaging, electrodes were scanned using
10 nm diameter AFM ContAl-G tips (BudgetSensors, Bulgaria), followed by image processing using
Bruker’s version 1.5 NanoScope Analysis software. Scanning electrode microscopy (SEM) studies
were performed to confirm selective PPY-COOH deposition on the electrodes using a JEOL JSM-6480
SEM (JEOL, Peabody, MA, USA). For TNF-α detection and estimation, differential pulse voltammetry
(DPV) measurements were performed at −0.2–0.45 V under the applied 25 mV amplitude, 3 mV step
potential, 0.03 s interval time, 0.02 s modulation time and 100 mV/s scan rate.
2.3. Gold Electrode Preparation
Counter and pseudo reference electrodes, along with interdigitated working electrodes of gold,
were fabricated using lithography and micro-fabrication processes on silicon oxide/silicon substrates [37].
In sensor development, one side of the interdigitated electrode possessing 3200 µm long and 5 µm
wide electrodes at a 25 µm gap, spread over a 5500 µm length, was used as the working electrode.
Fabricated electrodes were cleaned using ethanol, acetone and deionized H2O followed by UV-ozone
treatment for half an hour before utilization.
2.4. PPy-COOH Deposition and Anti-TNF-α Immobilization
Before PPy-COOH deposition onto fresh clean gold electrodes, a chamber covering the
interdigitated area was made using laser cut tape, capable of holding 50 to 100 µL of solution
(Figure 1). For electrochemical deposition, 50 µL of 50 mM pyrrole-COOH in 0.5 M LiClO4 in H2O was
poured into the chamber and PPy-COOH was electrochemically deposited via sweeping the voltage at
50 mV/s between −0.1 and 0.8 V. Five voltage sweeps were applied through cyclic voltammetry for
optimum film deposition. After electrochemical deposition, the PPy-COOH film was washed with
miliQ water and dried by gentle air blow. Before anti-TNF-α immobilization, the carboxylic groups
on the PPy-COOH film were activated by incubating the PPy-COOH modified surface with 50 µL of
EDC (0.4 M)/NHS (0.1 M) in H2O for 30 min. After activation, the electrode was washed with H2O
and then with PBS (10 mM, pH 7.4). Extra PBS was removed from the electrode surface and treated
with 50 µL of anti-TNF-α (10 µg/mL) in PBS for 90 min at room temperature. The antibody modified
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surface was then rinsed with PBST and PBS followed by incubation in 50 µL SB for 1 h to block empty
sites and to prevent nonspecific binding. After incubation, the extra SB was decanted and the prepared
Au/PPy-COOH/anti-TNF-α/SB electrodes were kept at 4 ◦C for storage. Figure 1b illustrates the steps
involved in Au/PPy-COOH/anti-TNF-α/SB bioelectrode fabrication and immunoassay.
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Figure 1. (a) Optical image of fabricated chip with laser cut chamber; (b) schematic for Au/PPy-COOH/
anti-TNF-α/SB electrode fabrication and immunoassay.
2.5. TNF-α Bindi g and Estimation Studies
For TNF-α binding and estimation, Au/PPy-COOH/anti-TNF-α/SB bioelectrodes were treated
with the chosen concentrations of TNF-α spiked in serum. The electrodes were tested for incubation
times of 10, 20, 30 and 40 min for optimization. Optimum response was observed when electrodes
were treated with antigen, secondary antibody and enzyme tag for 30 min each and then incubated
with enzyme substrate for 20 min before the electrochemical measurement. Thus, 30 min incubations
for the initial 3 steps and 20 min incubation for last step were used in this study for the sensing. For the
immunoassay, the following steps were performed at room temperature (22 ± 1 ◦C) in a sequential
manner:
1. Antigen incubation: 30 min.
2. Washing using washing buffer (Femto TBST, 1x): three times.
3. Interaction with biotin modified secondary antibody solution (50µL, 10µg/mL) in SB-TBST: 30 min.
4. Washing using washing buffer (Femto TBST, 1x): three times.
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5. Interaction with streptavidin modified alkaline phosphatase (ALP) or polymeric alkaline
phosphatase (PALP) solution (50 µL, 10 µg/mL) in SB-TBST: 30 min.
6. Washing using washing buffer (Femto TBST, 1x): three times.
7. Final interaction with 50 µL of 2 mg/mL 4-APP in de-aerated tris-HCl buffer (100 mM, pH 9.0
containing 4 mg/mL MgCl2·6H2O): 20 min.
8. Electrochemical oxidation signal recording using differential pulse voltammetry.
The developed Au/PPy-COOH/anti-TNF-α/SB bioelectrode was also tested for protein interference
studies in non-spiked serum and in serum samples spiked with human epidermal growth factor
receptor 2 (HER2), C-reactive protein (CRP) and prostate-specific antigen (PSA). Each experiment was
carried out in triplicate on three separate electrodes and shown using error bars.
3. Results and Discussion
3.1. EIS and CV Investigations
The Au/PPy-COOH/anti-TNF-α/SB bioelectrode fabrication was characterized at each step using
CV and EIS (Figure 2). After PPy-COOH deposition, a slight decrease in current and slight increase
in charge transfer resistance (Rct) was observed (Figure 2a,b). Such small but significant changes
indicated the deposition of a very thin PPy-COOH film of around 11 nm, as confirmed via the
AFM study. Scan rate studies (Figure 2c,d) further suggest that polymer deposition does not affect
significantly the conducting properties of the gold electrode and exhibit similar redox behavior as
showed by the bare gold electrode. Furthermore, in scan rate studies between 30 and 100 mV/s using
CV, electrode showed linear variation in peak current with a square root of scan rate (Figure 2e,f),
indicating a diffusion-controlled process [38]. CV and EIS studies and comparison of the electrodes
with and without PPy-COOH on adjacent electrodes on the same chip (Figure 2g,h) suggest that
PPy-COOH deposition occurs selectively on the desired electrode, while the other electrode without
PPy-COOH shows CV and EIS responses similar to the electrode just kept immersed in polymerization
solution without applying any voltage or CV scans. The lower current response and higher Rct in the
non-modified electrode kept immersed in polymerization solution compared to the fresh clean blank
electrode may be attributed to the adsorption of non-conducting molecules of pyrrole on the fresh
clean gold surface. The difference in electrode with and without PPy-COOH on the same chip is also
clearly visible in SEM images (Figure 3a).
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Figure 2. Characterization of Au/PPy-COOH/anti-TNF-α/SB electrode fabrication using (a) electrochemical
impedance spectroscopy (EIS) and (b) cyclic voltammetry (CV). Scan rate study of (c) blank Au,
(d) PPy-COOH/Au. (e,f) show the changes in peak current with square root of scan rate for (c,d),
respectively. Study of electrode incubation effect in polymerization solution via (g) EIS and (h) CV.
3.2. SEM and AFM Characterization for PPy-COOH Deposition
PPy-CO H depositi lso confirmed using SEM and AFM studies. Figure 3a s ows the
SEM image of electrode with PPy-COOH d posited on ne side of int rdigitated electrode,
which was used as the working lectrode. The dark color on one side of interdigitated lectrode
suggested successful deposition of PPy-COOH, whereas the clear shining electrode suggested no
deposition on PPy-COOH on the other pair of interdigitated electrodes. AFM studies were further
used to confirm PPy-COOH deposition and to measure the thickness of the deposited polymer.
A clear change in morphology from spiky in un-modified gold electrode (Figure 3c) to globular after
deposition of PPy-COOH (Figure 3d) further confirmed the successful deposition of PPy-COOH.
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Further, AFM scanning was used to measure the height of two sides of electrode fingers with and
without PPy-COOH on the same chip and found to be around 11 nm via step analysis (Figure 3b).
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3.3. Differential Pulse Voltammetric Studies for TNF-α Detection
Different concentrations of TNF-α (cTNF-α) between 100 pg/mL and 100 ng/mL in pure serum
were investigated with the Au/PPy-COOH/anti-TNF-α/SB bioelectrode via DPV (Figure 4a). Analysis
of Figure 4a revealed that the sensor is insensitive to serum proteins, as no response was observed for
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serum. Also, the Au/PPy-COOH/anti-TNF-α/SB bioelectrode showed no signal up to 1 ng/mL of TNF-α,
indicating no sensitivity for such low concentrations. For concentrations of 5 ng/mL and above, the peak
current was found to increase with the increase in concentration, indicating successful bioassay and
ability of the Au/PPy-COOH/anti-TNF-α/SB bioelectrode for TNF-α detection in serum. The increasing
peak current with cTNF-α corresponds to the increasing concentration of 4-amino phenol produced in
the biocatalyzation of 4-APP by captured ALP-streptavidin during bioassay. With higher production
of 4-amino phenol, a higher electrochemical oxidation current was observed during the DPV scans.
The enlarged image shown in Figure 4b reveals a distinctive signal from 5 ng/mL. Further, analysis
shown in Figure 4c suggests a linear behavior of the Au/PPy-COOH/anti-TNF-α/SB bioelectrode for
TNF-α detection, which can be represented as I (µA) = 0.38 µA + 0.054 µA/(ng/mL) cTNF-α (ng/mL).
Moreover, a sensitivity of 54 nA/(ng/mL) and limit of detection of 85 pg/mL (3xSD of blank/sensitivity)
were observed for the Au/PPy-COOH/anti-TNF-α/SB electrode. The 5% error observed in the triplicated
set of experiments shown via the error bars indicated acceptable repeatability. The results of these
studies using the Au/PPy-COOH/anti-TNF-α/SB electrode indicate the suitability of using PPy-COOH
modified gold surface for the development of a new biosensor platform for the detection and estimation
of biologically relevant protein biomarkers in real samples.
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Figure 4. (a) Differential pulse voltammetry (DPV) studies for TNF-α spiked serum in the
100 pg/mL–100 ng/mL range using the Au/PPy-COOH/anti-TNF-α/SB bioelectrode; (b) DPV studies for
the Au/PPy-COOH/anti-TNF-α/SB electrode towards TNF-α concentration up to 10 ng/mL; (c) Linear
range analysis of the Au/PPy-COOH/anti-TNF-α/SB electrode towards TNF-α concentration.
To improve the observed characteristics for the developed sensor in a lower concentration range,
further studies were made using polymeric APL. Figure 5a shows the DPV spectra for spiked serum with
TNF-α in the 100 pg/mL–100 ng/mL range using the Au/PPy-COOH/anti-TNF-α/SB sensor, when tested
with PALP. The results clearly indicate more than seven times higher sensitivity and current response
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than with standard ALP. Furthermore, the DPV spectra for lower concentrations (Figure 5b) indicated
that TNF-α detection using PALP results in a clear and distinguishable response, even at 100 pg/mL.
Even though the use of PALP resulted in a higher response to un-spiked serum, the response for
100 pg/mL was much higher and clearly distinctive. Better and higher response indicated the presence
of a larger number of ALP molecules per antigen captured during antibody–antigen interactions.
Further analysis shown in Figure 5c suggests enhanced linear behavior of the sensors towards TNF-α
detection, which can be represented as I (µA) = 1.44 µA + 0.383 µA/(ng/mL) cTNF-α (ng/mL). Moreover,
sensitivity of 383 nA/(ng/mL) and limit of detection of 78 pg/mL was obtained in this case. The 5%
error observed in triplicated set of experiment shown via error bars indicates acceptable reproducibility
and consistency of the electrodes prepared. Furthermore, the sensors were stable for periods of up to
4 weeks when stored at 4 ◦C. The enhanced characteristics observed with the use of PALP for TNF-α
estimation in spiked serum clearly suggest that the PALP approach provides the opportunity of using
PPy-COOH-modified gold surface for the development of a new biosensor platform with enhanced
and sensitive detection and estimation of biologically relevant protein biomarkers in real samples.
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Figure 5. (a) DPV studies for TNF-α spiked serum in the 100 pg/mL–100 ng/mL range using
Au/PPy-COOH/anti-TNF-α/SB electrode with PALP; (b) DPV studies for the Au/PPy-COOH/
anti-TNF-α/SB electrode towards TNF-α concentration up to 1 ng/mL; (c) Linear range analysis
of the Au/PPy-COOH/anti-TNF-α/SB electrode towards TNF-α concentration.
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3.4. Interference Studies from Other Proteins
The response of the sensor towards proteins in serum as well as towards protein biomarkers such
as HER2, CRP and PSA at 100 ng/mL in spiked serum was studied in order to investigate interference
effects. Figure 6 shows the DPV responses of the Au/PPy-COOH/anti-TNF-α/SB bioelectrode for various
possible interferents: non-spiked serum; 100 ng/mL of HER2, CRP and PSA in serum. The results
clearly show the selectivity of the sensor for TNF-α, with negligible response to HER2, CRP, PSA or
proteins in serum. Thus, the Au/PPy-COOH/anti-TNF-α/SB bioelectrode offered a viable platform to
estimate protein markers in real samples. Table 1 compares the results of the present study with other
reported results for TNF-α, clearly suggesting that the Au/PPy-COOH/anti-TNF-α/SB bioelectrode can
be used to get a better response in a wide dynamic range in undiluted serum samples.
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Table 1. Characteristics of the the Au/PPy-COOH/anti-TNF-α/SB bioelectrode and those reported in
the literature.
Sensor SampleMedium
Detection
Method
Linearity
(ng/mL)
Detection
Limit (ng/mL) Ref.
SB/EA/anti-TNF-α/DTSP
SAM/Au
Undiluted
serum DPV 0.5–100 0.06 [4]
MB/TNF-α aptamer SAM/ Au Cell culturemedium SWV 9–88 5.46 [39]
BSA/anti-TNF-α/MUA
SAM/Au Buffer QCM 40–2000 25 [40]
BSA/anti-TNF-α/DNA
nanostructure/Au 1% BSA in PBS Amperometry 0.1−2.5 0.1 [41]
SB/anti-TNF-α/PPy-COOH/Au Undilutedserum DPV 0.1–100 0.078 present work
DPV: differential pulse voltammetry; DTSP: dithiobis(succini idyl propionate); EA: ethanolamine; MB: methylene
blue; MUA: mercaptoundecanoic acid; QCM: quartz crystal microbalance; SAM: self-assembled monolayer;
SWV: square wave voltammetry
4. Conclusions
In summary, the PPy-COOH matrix-based system with PALP tag-based enhancement strategy
offered a novel electrochemical ELISA biosensor system to measure protein biomarkers in undiluted
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serum in a selective and specific manner with enhanced sensitivity. The Au/PPy-COOH/anti-TNF-α/SB
bioelectrode with PALP conjugated reagents showed linear response for TNF-α estimation in the range
100 pg/mL–100 ng/mL. The developed system showed a sensitivity of 383 nA/(ng/mL) and a limit of
detection of 78 pg/mL. The sensor further exhibited selectivity for TNF-α with negligible signals for
HER2, CRP, PSA and other serum protein. The results of the present study clearly suggest that the
PALP approach with a PPy-COOH-based electrochemical ELISA platform provides a new opportunity
for enhanced and sensitive detection and estimation of protein biomarkers in serum. With the use
of suitable antibodies, the technique can be expanded to the detection of a wide range of clinically
relevant biomarkers in real samples. The electrochemical detection allows for miniaturization and
multiplexing in low-cost systems.
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